MiJory
MiJory provides a unified operating system for high-growth health and longevity companies, integrating four wholly owned platforms—BioTide USA, RxPath, TrakPath, and Sentynl—for supply verification, clinical care, and real-world data intelligence. The asset-light company takes a fee slice of transaction volume across wellness, clinical labs, and peptide therapeutics, targeting a $65.0B serviceable market.
- Healthcare Technology
- Digital Health
- Commerce & Shopping
- Software Only
- Data & Analytics
- Artificial Intelligence
- Biotechnology
- Blockchain & Cryptocurrency
- Clean Technology
- Logistics & Supply Chain
- Retail Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Organizations across regulated industries often struggle with fragmented point solutions that do not communicate with one another, creating operational inefficiencies, data silos, and compliance gaps. Managing multiple disconnected systems increases overhead, slows decision-making, and exposes businesses to security and audit risks.
Solution
MiJory LLC provides a unified ecosystem portfolio that integrates multiple specialized products into a cohesive platform, described as "the operating system for high-growth health and longevity." The portfolio—which includes BioTide USA, RxPath, TrakPath, and Sentynl—addresses distinct operational challenges while sharing a common architectural foundation. BioTide USA and RxPath drive commercial and clinical scale, while TrakPath and Sentynl expand high-margin software and data economics across the ecosystem. All products are built to align with SOC 2 audit-ready architecture, reducing the burden of demonstrating compliance across separate systems. MiJory operates as an asset-light trust and routing layer, partnering with enterprise fulfillment, diagnostics, and manufacturing capacity providers rather than bearing manufacturing CapEx.
Target Audience
MiJory serves organizations in regulated industries—including healthcare, life sciences, wellness, and supply chain—that need integrated, compliance-ready technology solutions to manage specialized workflows and capture value in the longevity and clinical services market.
Features
- Unified ecosystem architecture spanning four product lines: BioTide USA, RxPath, TrakPath, and Sentynl
- TrakPath provides verification and provenance capabilities for supply chain integrity
- RxPath delivers clinical and telehealth services for specialized care delivery
- Sentynl offers Trust Graph™ intelligence for real-world data analytics
- BioTide USA enables commerce and supply operations across the ecosystem
- SOC 2 audit-ready design that streamlines security and compliance validation across the portfolio
- Modular deployment enables customers to adopt individual solutions or combine them for broader operational coverage
- Asset-light model with strategic scale partners owning fulfillment, diagnostics, and manufacturing capacity
- High-margin fee model applied to transaction volume across wellness, clinical labs, peptide therapeutics, and adjacent longevity verticals